Female Infertility

Yen and Jaffe's Reproductive Endocrinology: Seventh Edition

Volumn , Issue , 2013, Pages 512-537

  Barbieri, Robert L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903259115     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-2758-2.00023-8     Document Type: Chapter

References (313)

1. Bushnik T., Cook J.L., Yuzpe A.A., Tough S., et al. Estimating the prevalence of infertility in Canada. Hum Reprod 2012, 27:738-746.
2. Slama R., Hansen O.K.H., Ducot B., Bohet A., et al. Estimation of the frequency of involuntary infertility on a nation-wide basis. Hum Reprod 2012, 1489-1498.
3. Bhattacharya S., Porter M., Amalraj E., Templeton A., et al. The epidemiology of infertility in the North East of Scotland. Hum Reprod 2009, 24:3096-3107.
4. Stephen E.H., Chandra A. Declining estimates of infertility in the United States: 1982-2002. Fertil Steril 2006, 86:516-520.
5. Brosens I., Gordts S., Valkenburg M., Puttermans P., Campo R., Gordts S. Investigation of the infertile couple; when is the appropriate time to explore female infertility?. Hum Reprod 2004, 19:1689-1694.
6. Gnoth C., Godehardt D., Godehardt E., Frank-Hermann P., Freundl G. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Hum Reprod 2003, 18:1959-1963.
7. Hunault C.C., Habbema J.D.F., Eijkemans M.J.C., Collins J.A., Evers J.L.H., te Velde E.R. Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Human Reprod 2004, 19:2019-2024.
8. Cramer D.W., Walker A.M., Schiff I. Statistical methods in evaluating the outcome of infertility therapy. Fertil Steril 1979, 32:80-86.
9. Guttmacher A.F. Factors affecting normal expectancy of conception. JAMA 1956, 161:855-860.
10. Zinaman M.J., Clegg E.D., Brown C.C., et al. Estimates of human fertility and pregnancy loss. Fertil Steril 1996, 65:503-509.
11. Wilcox A.J., Weinburg C.R., O'Connor J., et al. Incidence of early loss of pregnancy. N Engl J Med 1988, 319:189-194.
12. Bloch S.K. Occult pregnancy: a pilot study. Obstet Gynecol 1976, 48:365-368.
13. Bolvin J., Bunting L., Collins J.A., et al. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 2007, 22:1506-1512.
14. WHO Technical Report Series. Recent Advances in Medically Assisted Conception Number 820, 1992, pp 1-111.
15. Collins J.A. Unexplained infertility. Infertility: Evaluation and Treatment 1995, 249-262. WB Saunders, Philadelphia. W.R. Keye, R.J. Chang, R.W. Rebar, M.R. Soules (Eds.).
16. Smith S., Pfeifer S.M., Collins J.A. Diagnosis and management of female infertility. JAMA 2003, 290:1767-1771.
17. Freeman E.W., Sammel M.D., Lin H., Gracia C.R. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab 2012, epub Feb 29.
18. Rice J.P., London S.N., Olive D.L. Reevaluation of hysterosalpingography in infertility investigation. Obstet Gynecol 1986, 67:718-721.
19. Lim C.P., Hasafa Z., Bhattacharya S., Maheshwari A. Should a hysterosalpingogram be a first-line investigation to diagnose female tubal subfertility in the modern subfertility workup?. Hum Reprod 2011, 26:967-971.
20. La Sala G.B., Blasi I., Gallinelli A., Debbi C., et al. Diagnostic accuracy of sonohysterography and transvaginal sonography as compared with hysteroscopy and endometrial biopsy: a prospective study. Minerva Ginecol 2011, 63:421-427.
21. Glatstein I.Z., Best C.L., Palumbo A., et al. The reproducibility of the postcoital test. Obstet Gynecol 1995, 85:396-400.
22. Griffiths C.S., Grimes D.A. The validity of the postcoital test. Am J Obstet Gynecol 1990, 162:615-619.
23. Oei S.G., Helmerhorst F.M., Bloemenkamp K.W., et al. Effectiveness of the postcoital test: randomized controlled trial. BMJ 1998, 317:502.
24. Coutifaris C., Myers E.R., Guzick D.S., et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 2004, 82:1264-1271.
25. Broekmans F.J., Soules M.R., Fauser B.C. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009, 30:465-493.
26. Malcolm C.E., Cumming D.C. Does anovulation exist in eumenorrheic women?. Obstet Gynecol 2003, 102:317-321.
27. Wilcox A.J., Weinberg C.R., Baird D.D. Timing of sexual intercourse in relation to ovulation. N Engl J Med 1995, 333:1517-1521.
28. Filicori M., Butler J.P., Crowley W.F. Neuroendocrine regulation of the corpus luteum in the human: evidence for pulsatile progesterone secretion. J Clin Invest 1984, 73:1638-1647.
29. Hull M.G., Savage P.E., Bromham D.R., et al. The value of a single serum progesterone measurement I the midluteal phase as a criterion of a potentially fertile cycle derived from treated and untreated conception cycles. Fertil Steril 1982, 37:355-360.
30. Cakmak H., Taylor H.S. Implantation failure: molecular mechanisms and clinical treatment. Hum Reprod Update 2011, 17:242-253.
31. Paulson R.J. Hormonal induction of endometrial receptivity. Fertil Steril 2011, 96:530-535.
32. Hamilton C.J., Wetzels L.C., Evers J.L., et al. Follicle growth curves and hormonal patterns in patients with the luteinized unruptured follicle syndrome. Fertil Steril 1985, 43:541-548.
33. Kerin J.F., Kirby C., Morris D., et al. Incidence of the luteinized unruptured follicle phenomenon in cycling women. Fertil Steril 1983, 40:620-626.
34. Scheenjes E., te Velde E.R., Kremer J. Inspection of the ovaries and steroids in serum and peritoneal fluid at various time intervals after ovulation in fertile women: implications for the luteinized unruptured follicle syndrome. Fertil Steril 1990, 54:38-41.
35. Behre H.M., Kuhlage J., Gabner C., et al. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Human Reprod 2000, 15:2478-2482.
36. McGovern P.G., Myers E.R., Silva S., et al. Absence of secretory endometrium after false-positive home urine luteinizing hormone testing. Fertil Steril 2004, 82:1273-1278.
37. Antaki R., Dean N.L., Lapensee L., Racicot M.H., et al. An algorithm combining ultrasound monitoring and urinary luteinizing hormone testing: a novel approach for intrauterine insemination timing. J Obstet Gynecol Can 2011, 33:1248-1252.
38. Reindollar R.H., Novak M., Tho S.P.T., McDonough P.G. Adult onset amenorrhea: a study of 262 patients. Am J Obstet Gynecol 1986, 155:531-543.
39. Laufer M.R., Floor A.E., Parsons K.E., et al. Hormone testing in women with adult onset amenorrhea. Gynecol Obstet Invest 1995, 40:200-203.
40. Frisch R.E. The right weight: body fat, menarche and ovulation. Baillieres Clin Obstet Gynecol 1990, 4:419-439.
41. Grodstein F., Goldman M.B., Cramer D.W. Body mass index and ovulatory infertility. Epidemiology 1994, 5:247-250.
42. Nutrition and reproduction in women. Human Reprod Update 2006, 12:193-199. The ESHRE Capri Workshop Group.
43. Pasquali R., Antenucci D., Casimirri E. Clinical and hormonal characteristics of obese and amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989, 68:173-178.
44. Clark A.M., Ledger W., Galletly C., et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reproduction 1995, 10:2705-2712.
45. Guzick D.S., Wing R., Smith D., et al. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril 1994, 61:598-604.
46. Musella M., Milone M., Bellini M., Sosa Fernandez L.M., et al. Effect of bariatric surgery on obesity-related infertility. Surg Obes Relat Dis 2011, Oct 6 epub.
47. Williams N., Caston-Balderrama A.L., Helmreich D., et al. Longitudinal changes in reproductive hormones and menstrual cyclicity in cynomolgus monkeys during strenuous exercise training: abrupt transition to exercise-induced amenorrhea. Endocrinology 2001, 142:2381-2389.
48. DeSouz M.J., Toombs R.J., Scheid J.L., O'Donnell E., West S.L., Williams N.I. High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures. Human Reprod 2010, 25:491-503.
49. Williams N.I., Reed J.L., Leidy H.J., Legro R.S., De Souza M.J. Estrogen and progesterone exposure is reduced in response to energy deficiency in women aged 25 to 40 years. Human Reprod 2010, 25:2328-2339.
50. Welt C.K., Chan J.L., Bullen J., Murphy R., Smith P., DePaoli A.M., Karalis A., Mantzoros C.S. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004, 351:987-997.
51. Chou S.H., Chamberland J.P., Liu X., Matarese G., Gao C., Stefanakis R., Brinkoetter M.T., Gong H., Arampatzi K., Mantzoros C.S. Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci 2011, 108:6586-6590.
52. Castellano J.M., Bentsen A.H., Mikkelsen J.D., Tena-Sempere M. Kisspeptins: bridging energy homeostasis and reproduction. Brain Res 2010, 1364:129-138.
53. Bates G.W., Bates S.R., Whitworth N.S. Reproductive failure in women who practice weight control. Fertil Steril 1982, 37:373-378.
54. Berga S., Marcus M.D., Loucks T.L., et al. Recovery of ovarian activity in women with functional hypothalamic amenorrhea who were treated with cognitive behavior therapy. Fertil Steril 2003, 80:976-981.
55. Kouba S., Hallstrom T., Lindholm C., Hirschberg A.L. Pregnancy and neonatal outcomes in women with eating disorders. Obstet Gynecol 2005, 105:255-259.
56. Chavarro J.E., Rich-Edwards J.W., Rosner B.A., Willett W.C. Iron intake and risk of ovulatory infertility. Obstet Gynecol 2006, 108:1145-1149.
57. Chavarro J.E., Rich-Edwards J.W., Rosner B.A., Willett W.C. Diet and lifestyle in the prevention of ovulatory disorder infertility. Obstet Gynecol 2007, 110:1050-1055.
58. Papaleo E., Unfer V., Baillargeon J.P., De Santis L., et al. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol 2007, 23:700-703.
59. Greenblatt R.B., Barfield W.E., Jungck E.C., Ray A.W. Induction of ovulation with MRL-41. JAMA 1961, 178:101-106.
60. Murdter T.E., Kerb R., Turpeinen M., Schroth W., et al. Genetic polymorphism of cytochrome P450 2D6 determines estrogen receptor activity of the major infertility drug clomiphene via its active metabolites. Hum Mol Genet 2012, 21:1145-1154.
61. Kerin J.F., Liu J.H., Phillipou G., Yen S.S.C. Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab 1985, 61:265-268.
62. Kettel L.M., Roseff S.J., Berga S.L., et al. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Fertil Steril 1993, 59:532-538.
63. Jones G.S., Moraes-Ruehsen M. Induction of ovulation with human gonadotropins and with clomiphene. Fertil Steril 1965, 16:461-466.
64. Vaitukaitis J.L., Bermudez J.A., Cargille C.M., et al. New evidence for an antiestrogenic action of clomiphene citrate in women. J Clin Endocrinol Metab 1971, 32:503-508.
65. Tobias A., Carr L.A., Voogt J.L. Effects of estradiol benzoate and clomiphene on tyrosine hydroxylase activity and on luteinizing hormone and prolactin levels in ovariectomized rat. Life Sci 1981, 29:711-715.
66. Miyake A., Tasaka K., Sakumoto T., et al. Clomiphene citrate induces luteinizing hormone release through hypothalamic luteinizing hormone releasing hormone in vitro. Acta Endocrinol 1983, 103:289-293.
67. Zhuang L., Adashi E.Y., Hsueh A.J. Direct enhancement of gonadotropin-stimulated ovarian estrogen biosynthesis by estrogen and clomiphene citrate. Endocrinology 1982, 110:2219-2225.
68. Adashi E.Y. Clomiphene citrate initiated ovulation: a clinical update. Semin Reprod Endocrinol 1986, 4:255-272.
69. Pildes R.B. Induction of ovulation with clomiphene. Am J Obstet Gynecol 1965, 466-473.
70. Van Campenhout J., Simard R., Leduc B. Antiestrogenic effect of clomiphene in the human being. Fertil Steril 1968, 19:700-706.
71. Consultation on the diagnosis and treatment of endocrine forms of female infertility. Tech Rep Series No 1976, 514. WHO Scientific Group Report.
72. Hull M.G., Knuth U.A., Murray M.A., Jacobs H.S. The practical value of the progestogen challenge test, serum estradiol estimation or clinical examination in assessment of the estrogen state and response to clomiphene in amenorrhea. Br J Obstet Gynecol 1979, 86:799-805.
73. Maruo T., Katayama K., Barnea E.R., Mochizuki M. A role for thyroid hormone in the induction of ovulation and corpus luteum function. Hormone Res 1991, 37(Suppl 1):12-15.
74. Turksoy R.N., Biller B.J., Farber M., et al. Ovulatory response to clomiphene citrate during bromocriptine failed ovulation in amenorrhea, galactorrhea and hyperprolactinemia. Fertil Steril 1982, 37:441-444.
75. Wu C.H., Winkel C.A. The effect of therapy initiation day on clomiphene citrate therapy. Fertil Steril 1989, 52:564-568.
76. Gysler M., March C.M., Mishell D.R., Bailey E.J. A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril 1982, 37:161-167.
77. O'Herlihy C., Pepperell R.J., Brown J.B., et al. Incremental clomiphene therapy: a new method for treating persistent anovulation. Obstet Gynecol 1981, 58:535-539.
78. Hammond M.G., Halme J.K., Talbert L.M. Factors affecting the pregnancy rate in clomiphene citrate induction in ovulation. Obstet Gynecol 1983, 62:196-202.
79. Imani B., Eijkemans M.J.C., te Velde E.R., et al. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligomenorrheic infertility. Fertil Steril 2002, 77:91-97.
80. Rossing M.A., Daling J.R., Weiss N.S., et al. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994, 331:771-776.
81. van Leeuwen F.E., Klip H., Mooij T.M., van de Swaluw A.M.G., et al. Risk of borderline and invasive ovarian tumors after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod 2011, 26:3456-3465.
82. Cramer D.W., Hutchinson G.B., Welch W.R., et al. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Instit 1983, 71:711-716.
83. Mosgaard B.J., Schou G., Lidegaard O., et al. Infertility, infertility drugs and invasive ovarian cancer: a case-control study. Fertil Steril 1997, 67:1005-1012.
84. Potashnik G., Lerner-Geva L., Genkin L., et al. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 1999, 71:853-859.
85. Capelo FO, Kumar A, Steinkampf MP, Azziz R. Laparoscopic evaluation following failure to achieve pregnancy after ovulation induction with clomiphene citrate, 80:1450-1455, 2003.
86. Swyer G.I., Radwanska E., McGarrigle H.H. Plasma estradiol and progesterone estimation for the monitoring of induction of ovulation with clomiphene and chorionic gonadotropin. Br J Obstet Gynecol 1975, 82:794-799.
87. Kosmas I.P., Tatsioni A., Fatemi H.M., et al. Human chorionic gonadotropin administration versus luteinizing hormone monitoring for intrauterine insemination timing after administration of clomiphene citrate. Fertil Steril 2007, 87:607-611.
88. Farhi J., Orvieto R., Gavish O., Homburg R. The association between follicular size on human chorionic gonadotropin day and pregnancy rate in clomiphene citrate treated polycystic ovary syndrome patients. Gynecol Endocrinol 2010, 26:546-548.
89. Zreik T.G., Garcia-Velasco J.A., Haboosh M.S., et al. Prospective randomized crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine inseminations in clomiphene citrate-stimulated treatment cycles. Fertil Steril 1999, 71:1070-1074.
90. Palopoli F.P., Feil V.J., Allen R.E., et al. Substituted aminoalkoxytriaryl-hodoethylenes. J Med Chem 1967, 10:84-87.
91. He D., Jiang F. Meta-analysis of letrozole versus clomiphene citrate in polycystic ovary syndrome. Reprod Biomed Online 2011, 23:91-96.
92. Rein M., Barbieri R.L., Greene M. High order multiple gestation associated with the use of clomiphene and human menopausal gonadotropin. Int J Fertil 1990, 35:154-156.
93. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008, 89:505-522. The Thessalonkiki ESHRE/ASRM Sponsored PCOS Consensus Workshop Group.
94. Elnashar A., Abdelmageed E., Fayed M., Sharaf M. Clomiphene citrate and dexamethasone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study. Hum Reprod 2006, 21:1805-1808.
95. Parsanezhad M.E., Alborzi S., Motazedian S., Omrani G. Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: placebo-controlled trial. Fertil Steril 2002, 78:1001-1004.
96. Isaacs J.D., Lincoln S.R., Cowan B.D. Extended clomiphene citrate (CC) and prednisone for the treatment of chronic anovulation resistant to CC alone. Fertil Steril 1997, 67:641-643.
97. Daly D.C., Walters C.A., Soto-Albors C.E., Tohan N., Riddick D.H. A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril 1984, 41:844-848.
98. Brown J., Farquhar C., Beck J., Boothroyd C., Hughes E. Clomiphene and anti-estrogens for ovulation induction in PCOS. Cochrane Database of Systemic Reviews 2009, Art No. CD002249.
99. Branigan E.F., Estes M.A. Treatment of chronic anovulation resistant to clomiphene by using oral contraceptive ovarian suppression followed by repeat clomiphene treatment. Fertil Steril 1999, 71:544-545.
100. Branigan EF, Estes MA: A randomized clinical trial of treatment of clomiphene resistant anovulation with the use of oral contraceptive pill suppression and repeat clomiphene citrate treatment. Am J Obstet Gynecol 188:1424-1429, 2013.
101. Jarrell J., Mclnnes R., Crooke R. Observations on the combination of clomiphene citrate-hMG-hCG in the management of anovulation. Fertil Steril 1981, 35:634-639.
102. Elkind-Hirsch K.E., Phillips K., Bello S.M., et al. Sequential hormonal supplementation with vaginal estradiol and progesterone gel corrects the effect of clomiphene on the endometrium in oligo-ovulatory women. Human Reprod 2002, 17:295-298.
103. Biljan M.M., Mahutte N.G., Tulandi T., Tan S.L. Prospective randomized double-blind trial of the correlation between time of administration and anti-estrogenic effects of clomiphene on reproductive end organs. Fertil Steril 1999, 71:633-638.
104. Laohaprasitiporn C., Barbieri R.L., Yeh J. Induction of ovulation with the sole use of clomiphene in the late onset 21-hydrxoylase deficiency. Gynecol Obstet Invest 1996, 41:224-227.
105. Kistner R.W. Sequential use of clomiphene and human menopausal gonadotropin in ovulation induction. Fertil Steril 1976, 27:72-77.
106. Jarrell J., McInnes R., Crooke R. Observations on the combination of clomiphene-hMG-hCG in the management of anovulation. Fertil Steril 1981, 35:634-637.
107. Shaw R.J., Lamia K.A., Vasquez D., et al. The kinase LKB1 mediates glucose homeostatis in liver and therapeutic effects of metformin. Science 2005, 310:1642-1646.
108. Legro R.S., Barnhart H.X., Schlaff W.D., et al. Clomiphene, metformin or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007, 356:551-558.
109. Palomba S., Orio F., Falbo A., Russo T., Tolino A., Zullo F. Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2007, 92:3498-3502.
110. Moll E., Korevaar J.C., Bossuyt P.M.M., van der Veen F. Does adding metformin to clomiphene lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome. Human Reprod 2008, 23:1830-1834.
111. Badawy A., Gibreal A. Clomiphene citrate versus tamoxifen for ovulation induction in women with PCOS: a prospective randomized trial. Eur J Obstet Gynecol Reprod Biol 2011, 159:151-154.
112. de Paula Guedes Neto E., Savaris R.F., von Eye Corieta H., de Moraes G.S., et al. Prospective, randomized comparison between raloxifene and clomiphene citrate for ovulation induction in polycystic ovary syndrome. Fertil Steril 2011, 96:769-773.
113. Fozan H., Khadouri M., Tan S.L., Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 2004, 82:1561-1565.
114. Treadway D., Schertz J.C., Bock D., Hemsey G., et al. Anastrozole versus clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized dose-finding study. Fertil Steril 2011, 95:1720-1724.
115. Mitwally M.F., Biljan M.M., Casper R.F. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005, 192:381-385.
116. Tulandi T., Martin J., Al-Fadhli R., et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene. Fertil Steril 2006, 85:1761-1766.
117. Azim A., Oktay K. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil Steril 2007, 88:657-661.
118. Oktay K., Hourvitz A., Sahin G., et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006, 91:3885-3891.
119. Azim A.A., Costantini-Ferrando M., Lostritto K., Oktay K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 2007, 92:2197-2201.
120. Hashim H.A., Shokeir T., Badawy A. Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene resistant women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril 2010, 94:1405-1409.
121. McKnight K.K., Nodler J.L., Cooper J.J., Chapman V.R., et al. Body mass index-associated differences in response to ovulation induction with letrozole. Fertil Steril 2011, 96:1206-1208.
122. Felemban A., Tan S.L., Tulandi T. Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal. Fertil Steril 2000, 73:266-269.
123. Amer S.A.K., Li T.C., Cooke I.D. A prospective dose-finding study of the amount of thermal energy required for laparoscopic ovarian diathermy. Human Reprod 2003, 18:1693.
124. Abdel Gadir A., Mowafi R.S., Alnaser H.M., et al. Ovarian electro-cautery versus human menopausal gonadotropins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clin Endocrinol 1990, 33:585-592.
125. Farquhar C.M., Williamson K., Gudex G., Johnson N.P., Garland J., Sadler L. A randomized controlled trial of laparoscopic ovarian diatherym versus gonadotropin therapy for women with clomiphene resistant polycystic ovary syndrome. Fertil Steril 2002, 78:404-408.
126. Bayram N., Van Wely M., van der Veen F., Bossuyt P.M.M. Treatment preferences and trade-offs for ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 2005, 84:420-425.
127. Farquhar C.M., Williamson K., Brown P.M., Garland J. An economic evaluation of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate resistant polycystic ovary syndrome. Human Reprod 2004, 19:1110-1115.
128. Pirwany I., Tulandi T. Laparoscopic treatment of polycystic ovaries: is it time to relinquish the procedure. Fertil Steril 2003, 80:241-244.
129. Santoro N., Wierman M.E., Filicori M., et al. Intravenous administration of pulsatile gonadotropin releasing hormone in hypothalamic amenorrhea: effects of dosage. J Clin Endocrinol Metab 1986, 62:109-116.
130. Santoro N., Wierman M.E., Filicori M., et al. Intravenous administration of pulsatile gonadotropin releasing hormone in hypothalamic amenorrhea: effects of dosage. J Clin Endocrinol Metab 1986, 62:109-116.
131. Crowley W.F., McArthur J.W. Stimulation of the normal menstrual cycle in Kallmann's syndrome by pulsatile administration of luteinizing hormone releasing hormone. J Clin Endocrinol Metab 1980, 51:173-179.
132. Seibel M.M., Kamrava M., McArdle C., Taymor M.L. Ovulation induction and conception using subcutaneous pulsatile luteinizing hormone releasing hormone. Obstet Gynecol 1983, 61:292-297.
133. Martin K.A., Hall J.E., Adams J.M., Crowley W.F. Comparison of exogenous gonadotropins and pulsatile gonadotropin releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 1993, 77:125-129.
134. Davis O.K., Berkley A.S., Naus G.J., et al. The incidence of luteal phase defect in normal fertile women determined by serial endometrial biopsies. Fertil Steril 1989, 51:582-586.
135. Murray M.J., Meyer W.R., Zaino R.J., et al. A critical analysis of the accuracy, reproducibility and clinical utility of histological endometrial dating in fertile women. Fertil Steril 2004, 81:1333.
136. Usadi R.S., Groll J.M., Lessey B.A., Lininger R.A., et al. Endometrial development and function in experimentally induced luteal phase deficiency. J Clin Endocrinol Metab 2008, 93:4058-4064.
137. Csapo A.I., Pulkkinen M.O., Ruttner B., Sauvage J.P., Wiest W.G. The significance of the human corpus luteum in pregnancy maintenance. Am J Obstet Gynecol 1972, 112:1061-1065.
138. Daya S., Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst Rev 2004, CD004830.
139. Richardson S.J., Senikas V., Nelson J.F. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987, 65:1231-1237.
140. Faddy M.J., Gosden R.G. A mathematical model of follicle dynamics in the human ovary. Hum Reprod 1995, 10:770-775.
141. White Y.A., Woods D.C., Takai Y., Ishihara O., Seki H., Tilly J.L. Oocyte formation by mitotically active germ cells purified from ovaries by reproductive-age women. Nat Med 2012, 18:413-421.
142. Hansen K.R., Knowlton N.S., Thyer A.C., Charleston J.S., et al. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Human Reprod 2008, 23:699-708.
143. Rosen M.P., Johnstone E., McCulloch C.E., Schuh-Huerta S.M., et al. A characterization of the relationship of ovarian reserve markers with age. Fertil Steril 2012, 97:238-243.
144. Selesniemi K., Lee H.J., Muhlhauser A., Tilly J.L. Prevention of maternal aging-associated oocyte aneuploidy and meiotic spindle defects in mice by dietary and genetic strategies. Proc Natl Acad Sci 2011, 108:12319-12324.
145. Federation C.E.C.O.S., Schwartz D., Mayaux M.J. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. N Engl J Med 1982, 306:404-406.
146. Kline J.K., Kinney A.M., Levin B., Kelly A.C., et al. Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis. Hum Reprod 2011, 26:1537-1550.
147. Marca A.L., Giulini S., Tirelli A., Bertucci E., Marsella T., Xella S., Volpe A. Anti-mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Human Reprod 2007, 22:766-770.
148. Rombauts L., Onwude J.L., Chew H.W., Vollenhoven B.J. The predictive value of antral follicle count remains unchanged across the menstrual cycle. Fertil Steril 2011, 96:1514-1518.
149. Hendriks D.J., Mol B.W.J., Bancsi L.F.J., te Velde E.R., Broekmans F.J.M. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization. Fertil Steril 2005, 83:291-294.
150. Haadsma M.L., Bukman A., Groen H., et al. The number of small antral follicles determines the outcome of endocrine ovarian reserve tests in a subfertile population. Human Reprod 2007, 22:1925-1929.
151. McIlveen M., Skull J.D., Ledger W.L. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high risk IVF population. Hum Reprod 2007, 22:778-795.
152. Scott R.T., Leonardi M.R., Hofmann G.E., et al. A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population. Obstet Gynecol 1993, 82:539-545.
153. Sharara F.I., Beaste S.N., Leonardi M.R., et al. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test. Fertil Steril 1994, 62:257-262.
154. Jain T., Soules M.R., Collins J.A. Comparison of basal follicle stimulating hormone versus the clomiphene challenge test for ovarian reserve screening. Fertil Steril 2004, 82:180-185.
155. Al-Azemi M., Killick S.R., Duffy S., Pye C., et al. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction. Hum Reprod 2011, 26:414-422.
156. Toner J.P., Philput C.B., Jones G.S., Muasher S.J. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991, 55:784-791.
157. Yates A.P., Rustamov O., Roberts S.A., Lim H.Y.N., et al. Anti-mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF. Hum Reprod 2011, 26:2353-2362.
158. Hirokawa W., Iwase A., Goto M., Takikawa S., et al. The post-operative decline in serum antimullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod 2011, 26:904-910.
159. Hsu A., Arny M., Knee A.B., Bell C., et al. Antral follicle count in clinical practice: analyzing clinical relevance. Fertil Steril 2011, 95:474-479.
160. Jick H., Porter J., Morrison A.S. Relation between smoking and age of natural menopause. Lancet 1972, 1:1354-1355.
161. Cramer D.W., Barbieri R.L., Xu H., Reichart J.K.V. Determinants of basal follicle stimulating hormone levels in premenopausal women. J Clin Endocrinol Metab 1994, 79:1105-1109.
162. Westhoff C., Murphy P., Heller D. Predictors of ovarian follicle number. Fertil Steril 2000, 74:624-628.
163. Clark S.T., Radford J.A., Crowther D., et al. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. J Clin Oncol 1995, 13:134-139.
164. Agarwal S.K., et al. The dramatic fall in pregnancy rates with infertility therapy in women above the age of 35 years. Fertil Steril 1996, 65:759-763.
165. Toner J.P. Age equals egg quality, FSH level equals egg quantity. Fertil Steril 2003, 79:491-493.
166. Westrom L. Incidence prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980, 138:880-892.
167. Patton D.L., Askienazy-Elbhar M., Henry-Suchet J., et al. Detection of Chlamydia trachomatis in fallopian tube tissue in women with postinfectious tubal infertility. Am J Obstet Gynecol 1994, 171:95-101.
168. Akande V.A., Hunt L.P., Cahill D.J., et al. Tubal damage in infertile women: prediction using chlamydia serology. Human Reprod 2003, 18:1841-1845.
169. Hubacer D., Lara-Ricalde R., Taylor D. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001, 345:561-566.
170. Miller W.C., Ford C.A., Morris M., et al. Prevalence of chlamydia and gonococcal infections among young adults in the United States. JAMA 2004, 291:2229-2234.
171. Mueller B.A., Daling J.R., Moore D.E., et al. Appendectomy and the risk of tubal infertility. N Engl J Med 1986, 315:1506-1508.
172. DeCherney A.H., Mezer H.C. The nature of post tuboplasty pelvic adhesions as determined by early and late laparoscopy. Fertil Steril 1984, 41:643-649.
173. Diamond M.P., DeCherney A.H. Pathogenesis of adhesion formation/reformation: application to reproductive pelvic surgery. Microsurgery 1987, 8:103-107.
174. Hellebrekers B.W.J., Trimbos-Kemper T.C.M., Trimbos J.B., et al. Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertil Steril 2000, 74:203-212.
175. Diamond M.P., Linsky C.B., Cunningham T., et al. Synergistic effects of Interceed (TC7) and heparin in reducing adhesion formation in the rabbit uterine horn model. Fertil Steril 1991, 55:389-394.
176. Boyers S.P., Diamond M.P., DeCherney A.H. Reduction of postoperative pelvic adhesions in the rabbit with Gore-Tex surgical membrane. Fertil Steril 1998, 49:1066-1070.
177. Diamond M.P., Cunningham T., Linsky C.B., et al. Interceed (TC7) as an adjuvant for adhesion prevention: animal studies. Prog Clin Biol Re 1990, 358:131-143.
178. The efficacy of Interceed for prevention of reformation of postoperative adhesions on ovaries, fallopian tubes and fimbriae in microsurgical operations for fertility: a multi center study. Fertil Steril 1995, 63:709-714. Nordic Adhesion Prevention Group.
179. Franklin R.R. Reduction of ovarian adhesions by the use of Interceed: Ovarian Adhesions Study Group. Obstet Gynecol 1995, 86:335-340.
180. Stumpf P.G., March C.M. Febrile morbidity following hysterosalpingography: identification of risk factors and recommendations for prophylaxis. Fertil Steril 1980, 33:487-492.
181. Johnson N.P., Kwok R., Stewart A.W., Saththianathan M., et al. Lipiodol fertility enhancement: two year follow up of a randomized trial suggests a transient benefit in endometriosis, but a sustained benefit in unexplained infertility. Hum Reprod 2007, 22:2857-2862.
182. de Boer A.D., Vemer H.M., Willemsen W.N., Sanders F.B. Oil or aqueous contrast media for hysterosalpingography: a prospective randomized clinical study. Eur J Obstet Gynecol Reprod Biol 1988, 28:65-68.
183. Luciano D.E., Exacoustos C., Johns A., Luciano A.A. Can hysterosalpingo-contrast sonography replace hysterosalpingography in confirming tubal blockage after hysteroscopic sterilization and in the evaluation of the uterus and tubes in infertile patients?. Am J Obstet Gynecol 2011, 204. 79.e1-e5.
184. Ahinko-Hakamaa K., Huhtala H., Tinkanen H. The validity of air and saline hysterosalpingo-contrast sonography in tubal patency investigation before insemination treatment. Eur J Obstet Gynecol Reprod Biol 2007, 132:83-87.
185. Thomas K., Coughlin L., Mannion P.T., Haddad N.G. The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations. Hum Reprod 2000, 15:1079-1082.
186. El Hakim E.A., Gordon U.D., Akande V.A. The relationship between serum Chlamydia antibody levels and severity of disease in infertile women with tubal damage. Arch Gynecol Obstet 2010, 281:727-733.
187. The Practice Committee of the American Society of Reproductive Medicine Optimal evaluation of the infertile female. Fertil Steril 2006, 86:S264-S267.
188. Levison J.H., Barbieri R.L., Katz J.T., Loscalzo J. Hard to conceive. N Engl J Med 2010, 363:965-970.
189. Jindal U.N., Verma S., Bala Y. Favorable infertility outcomes following anti-tubercular treatment prescribed on the sole basis of a positive polymerase chain reaction test for endometrial tuberculosis. Hum Reprod 2012, 27:1368-1374.
190. Dlugi A.M., Reddy S., Saleh W.A., et al. Pregnancy rates after operative endoscopic treatment of total or near total distal tubal occlusion. Fertil Steril 1994, 62:913-920.
191. Canis M., Mage G., Pouly J.L., et al. Laparoscopic distal tuboplasty: report of 87 cases and a 4-year experience. Fertil Steril 1991, 56:616-621.
192. Schlaff W.D., Hassiakos D.K., Damewood M.D., Rock J.A. Neosalpingostomy for distal tubal obstruction: prognostic factors and impact of surgical technique. Fertil Steril 1990, 54:984-989.
193. Singhal V., Li T.C., Cooke I.D. An analysis of factors influencing the outcome of 232 consecutive tubal microsurgery cases. Br J Obstet Gynecol 1991, 98:628-636.
194. Sulak P.J., Letterie G.S., Hayslip C.C., et al. Hysteroscopic cannulation and lavage in the treatment of proximal tubal occlusion. Fertil Steril 1987, 48:493-494.
195. Thurmond A.S., Burry K.A., Novy M.J. Salpingitis isthmica nodosa: results of transcervical fluoroscopic catheter recanalization. Fertil Steril 1995, 63:715-722.
196. Honore G.M., Holden A.E., Schenken R.S. Pathophysiology and management of proximal tubal blockage. Fertil Steril 1999, 71:785-795.
197. The Practice Committee of the American Society of Reproductive Medicine Committee opinion: role of tubal surgery in the era of assisted reproductive technology. Fertil Steril 2012, 97:539-545.
198. Gordts S., Campo R., Puttemans P., Gordts S. Clinical factors determining pregnancy outcome after microsurgical tubal reanastomosis. Fertil Steril 2009, 92:1198-1202.
199. Istre O., Olsboe F., Trolle B. Laparoscopic tubal anastomosis: reversal of sterilization. Acta Obstet Gynecol Scand 1993, 72:680-681.
200. Rodgers A.K., Goldberg J.M., Hammel J.P., Falcone T. Tubal anastomosis by robotic compared with outpatient minilaparotomy. Obstet Gynecol 2007, 109:1175-1179.
201. Boeckxstaens A., Devroey P., Collins J., Tournaye H. Getting pregnant after tubal sterilization: surgical reversal or IVF. Hum Reprod 2007, 22:2660-2664.
202. Johnson N., Sowter M.C., Strandell A., Mol B.W. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2010, CD002125.
203. Practice Committee of the American Society of Reproductive Medicine Salpingectomy for hydrosalpinx prior to in vitro fertilization. Fertil Steril 2008, 90:S66-S69.
204. Mukherjee T., Copperman A.B., McCafrey C., et al. Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: a case for prophylactic salpingectomy. Fertil Steril 1996, 66:851-853.
205. Johnson N.P., Mak W., Sowter M.C. Laparoscopic salpingectomy for women with hydrosalpinges enhances the success of IVF. Human Reprod 2002, 17:543-547.
206. Strandell A., Lindhard A., Waldenstrom U., et al. Hydrosalpinx and IVF outcome: a prospective randomized multicenter trial in Scandinavia on salpingectomy prior to IVE. Hum Reprod 1999, 14:2762-2769.
207. Sagoskin A.W., Lessey B.A., Mottla G.L., et al. Salpingectomy or proximal tubal occlusion of unilateral hydrosalpinx increases the potential for spontaneous pregnancy. Human Reprod 2003, 18:2634-2638.
208. Kontoravdis A., Makrakis E., Pantos K., Botsis D., et al. Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertil Steril 2006, 86:1642-1649.
209. Darwish A.M., El Saman A.M. Is there a role for hysteroscopic tubal occlusion of functionless hydrosalpinges prior to IVF/ICSI in modern practice?. Acta Obstet Gynecol Scand 2007, 86:1484-1489.
210. Sugiura-Ogasawara M., Ozaki Y., Kitaori T., Kumagai K., et al. Midline uterine defect size is correlated with miscarriage of euploid embryos in recurrent cases. Fertil Steril 2010, 93:1983-1988.
211. Hua M., Odibo A., Longman R.E., et al. Congenital uterine anomalies and adverse pregnancy outcomes. Am J Obstet Gynecol 2011, 205. 558.e1-5.
212. Jette N.T., Glass R.H. Prognostic value of the postcoital test. Fertil Steril 1972, 23:29-32.
213. Kovacs G.T., Newman G.B., Henson G.L. The postcoital test: what is normal?. BMJ 1978, 23:29-32.
214. Collins J.A., So Y., Wilson E.H., et al. The postcoital test as a predictor of pregnancy among 355 infertile couples. Fertil Steril 1984, 41:703-708.
215. Glatstein I.Z., Best C.L., Palumbo A., et al. The reproducibility of the postcoital test: a prospective study. Obstet Gynecol 1995, 85:396-400.
216. Stillman R.J., Miller L.C. Diethylstilbestrol exposure in utero and endometriosis in infertile females. Fertil Steril 1984, 41:369-373.
217. Samson S.L.A., Bentley J.R., Fahey T.J., McKay D.J., Gill G.H. The effect of LOOP electrosurgical excision procedure on future pregnancy outcome. Obstet Gynecol 2005, 105:325-329.
218. Clementini E., Palka C., Iezzi I., et al. Prevalence of chromosomal abnormalities in 2078 infertile couples referred for assisted reproductive techniques. Human Reprod 2005, 20:437-442.
219. Layman L.C. BMP15- The first true ovarian determinant gene on the X-chromosome. J Clin Endocrinol Metab 2006, 91:1673-1678.
220. Kaufman F.R., Reichardt J.K., Ng W.G., et al. Correlation of cognitive neurologic and ovarian outcome with the Q188R mutation of the galactose-1-phosphate uridyl transferase gene. J Pediatr 1994, 125:225-227.
221. Aittomaki K., Dieguez Luccena J.L., Pakarinen P., et al. Mutation in the follicle stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995, 82:959-968.
222. Bentov Y., Kenigsberg S., Casper R.F. A novel luteinizing hormone/chorionic gonadotropin receptor mutation associated with amenorrhea, low oocyte yield and recurrent pregnancy loss. Fertil Steril 2012, 97:1165-1168.
223. Ishizuka B., Okamoto N., Hamada N., et al. Number of CGG repeats in the FMR1 gene of Japanese patients with primary ovarian insufficiency. Fertil Steril 2011, 96:1170-1174.
224. Crisponi I., Deiana M., Loi A., et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001, 27:159-166.
225. Di Pasquale E., Rossetti R., Marozzi A., et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 2006, 91:1976-1981.
226. Lourenco D., Brauner R., Lin L., De Perdigo A., et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med 2009, 360:1200-1210.
227. Christin-Maitre S., Vasseur C., Portnoi M.F., Bouchard P. Genes and premature ovarian failure. Mol Cell Endocrinol 1998, 145:75-80.
228. Osborne E.C., Lynch M., McLachlan R., Trounson A.O., et al. Microarray detection of Y chromosome deletions associated with male infertility. Reprod Biomed Online 2007, 15:673-680.
229. Talkowski M.E., Ernst C., Heilbut A., Chiang C., et al. Next-generation sequencing strategies enable routine detection of balanced chromosome rearrangements for clinical diagnostics and genetic research. Am J Hum Genet 2011, 88:469-481.
230. Ray A., Shah A., Gudi A., Homburg R. Unexplained infertility: an update and review of practice. Reprod Biomed Online 2012 March 7, epub.
231. Tanahatoe S., Hompes P.G.A., Lambalk C.B. Accuracy of diagnostic laparoscopy in the infertility work-up before intrauterine insemination. Fertil Steril 2003, 79:361-365.
232. Moayeri S.E., Lee H.C., Lathi R.B., Westphal L.M., et al. Laparoscopy in women with unexplained infertility: a cost-effectiveness analysis. Fertil Steril 2009, 92:471-480.
233. Blacker C.M., Ginsburg K.A., Leach R.E., et al. Unexplained infertility: evaluation of the luteal phase. Fertil Steril 1997, 67:437-442.
234. Guzick D.S., Carson S.A., Coutifaris C., et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. N Engl J Med 1999, 340:177-183.
235. Hull M.G., Williams J.A., Ray B., et al. The contribution of subtle oocyte or sperm dysfunction affecting fertilization in endometriosis associated or unexplained infertility. Human Reprod 1998, 13:1825-1830.
236. Hull M.G. Effectiveness of infertility treatments: choice and comparative analysis. Int J Obstet Gynecol 1994, 47:99-108.
237. Van Voorhis B.J., Stovall D.W., Sparks A.E.T., et al. Cost-effectiveness of infertility treatments: a cohort study. Fertil Steril 1997, 67:830-836.
238. ESHRE Task Force on Ethics and Law. Lifestyle-related factors and access to medically assisted reproduction. Hum Reprod 2010, 25:578-583.
239. Practice Committee of the American Society for Reproductive Medicine Optimizing natural fertility. Fertil Steril 2008, 80(Suppl 3):S1-S6.
240. Barbieri R.L. The initial fertility consultation: recommendations concerning cigarette smoking, body mass index and alcohol and caffeine consumption. Am J Obstet Gynecol 2001, 185:1168-1173.
241. Wise L.A., Rothman K.J., Mikkelsen E.M., Sorensen H.T., et al. An internet-based prospective study of body size and time-to-pregnancy. Hum Reprod 2010, 25:253-264.
242. Vatyavanich T., Collins J.A. An overview of the Canadian Infertility Therapy Evaluation study. J Soc Obstet Gynecol Can 1991, 13:29-34.
243. Chavarro J.E., Rich-Edwards J.W., Rosner B.A., Willett W.C. Protein intake and ovulatory infertility. Am J Obstet Gynecol 2008, 198. 210.e1-e7.
244. Toledo E., Lopez-del Burgo C., Ruiz-Zambrana A., Donazar M., et al. Dietary patterns and difficulty conceiving: a nested case-control study. Fertil Steril 2011, 96:1149-1153.
245. Attaman J.A., Toth T.L., Furtado J., Campos H., Hauser R., Chavarro J.E. Hum Reprod 2012, 27:1466-1474.
246. Robinson J.E., Wakelin M., Ellis J.E. Increased pregnancy rate with use of the ClearBLue Easy fertility monitor. Fertil Steril 2007, 87:329-334.
247. Wilcox A.J., Dunson D.B., Weinberg C.R., Trussell J., et al. Likelihood of conception with a single act of intercourse: providing benchmark rates for assessment of post-coital contraceptives. Contraception 2001, 63:211-215.
248. Stanford J.B., Dunson D.B. Effects of sexual intercourse patterns in time to pregnancy studies. Am J Epidemiol 2007, 165:1088-1095.
249. Custers I.M., van Rumste M.M.E., van der Steeg J.W., van Wely M., et al. Long-term outcome in couples with unexplained subfertility and an intermediate prognosis initially randomized between expectant management and immediate treatment. Hum Reprod 2012, 27:444-450.
250. Wordsworth S., Buchanan J., Mollison Harrild K., et al. Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost-effective?. Hum Reprod 2011, 26:369-375.
251. van den Boogaard N.M., Rengerink K.O., Steures P., Bossuyt P.M., et al. Tailored expectant management: risk factors for non-adherence. Hum Reprod 2011, 26:1784-1789.
252. Hunault C.C., Habbema J.D.F., Eijkemans M.J.C., Collins J.A., et al. Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Hum Reprod 2004, 19:2019-2026.
253. Hull M.G., Glazener C.M.A., Kelly N.H., et al. Population study of causes, treatment and outcome of infertility. Br Med J 1985, 291:1693-1697.
254. Cooke I.D. Donor insemination-timing and insemination method. 35th Royal College of Obstetricians and Gynecologists Study Group Evidence-Based Fertility Treatment 1998, RCOG Press, London. A. Templeton, I.D. Cooke, P.M.S. O'Brien (Eds.).
255. Ford W.C.L., Mathur R.S., Hull M.G.R. Intrauterine insemination: is it an effective treatment for male factor infertility. Balliere Clin Obstet Gynecol 1997, 11:691-710.
256. Polyzos N.P., Tzioras S., Mauri D., Tatsioni A. Double versus single intrauterine insemination for unexplained infertility: a meta-analysis of randomized trials. Fertil Steril 2010, 94:1261-1266.
257. Bagis T., Haydardedeoglu B., Kilidag E.B., Cok T., et al. Single versus double intrauterine insemination in multi-follicular ovarian hyperstimulation cycles: a randomized trial. Hum Reprod 2010, 25:1684-1690.
258. Ghanem M.E., Bakre N.I., Emam M.A., Al Boghdady L.A., et al. The effects of timing of intrauterine insemination in relation to ovulation and the number of inseminations on cycle pregnancy rate in common infertility etiologies. Hum Reprod 2011, 26:576-583.
259. Saleh A., Tan S.L., Biljan M.M., Tulandi T. A randomized study of the effect of 10 minutes of bed rest after intrauterine insemination. Fertil Steril 2000, 74:509-511.
260. Hughes E., Collins J., Vandekerckhove P. Clomiphene citrate for unexplained subfertility in women. Cochrane Database of Systemic Reviews 2000, CD000057.
261. Glazener C.M., Coulson C., Lambert P.A., et al. Clomiphene treatment for women with unexplained infertility. Gyn Endocrinol 1990, 4:75-83.
262. Merrill Dow Pharmaceuticals Product information bulletin 1972, Author, Cincinnati, Ohio.
263. Rein M., Barbieri R.L., Greene M. High order multiple gestation associated with the use of clomiphene and human menopausal gonadotropin. Int J Fertil 1990, 35:154-156.
264. Deaton J.L., Gibson M., Blackmer K.M., et al. A randomized controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis. Fertil Steril 1990, 54:1083-1088.
265. Zreik T.G., Garcia-Velasco J.A., Habboosh M.S., et al. Prospective, randomized crossover study to evaluate the benefit of human chorionic gonadotropin timed versus urinary luteinizing hormone timed intrauterine insemination in clomiphene citrate stimulated cycles. Fertil Steril 1999, 71:1070-1074.
266. Dovey S., Sneeringer R.M., Penzias A.S. Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles. Fertil Steril 2008, 90:2281-2286.
267. Agarwal S.K., Buyalos R.P. Clomiphene citrate with intrauterine insemination: is it effective therapy in women above the age of 35 years. Fertil Steril 1996, 65:759-763.
268. Serhal P.F., Katz M., Little V., Woronowski H. Unexplained infertility: the value of Pergonal Superovulation combined with intrauterine insemination. Fertil Steril 1988, 49:602-608.
269. Sher G., Knutzen V.K., Stratton C.J., et al. In vitro sperm capacitation and transcervical intrauterine insemination for the treatment of refractory infertility. Fertil Steril 1984, 41:260-264.
270. Dodson W.C., Whiteside D.B., Hughes C.L., et al. Superovulation with intrauterine insemination in the treatment of infertility. Fertil Steril 1987, 48:441-445.
271. Stewart J.A. Stimulated IUI is not a natural choice for the treatment of unexplained infertility. Human Reprod 2003, 18:903-907.
272. van Rumste M.M.E., den Hartog J.E., Dumoulin J.C.M., Evers J.L.H., Land J.A. Is controlled ovarian stimulation in intrauterine insemination an acceptable therapy in couples with unexplained non-conception in the perspective of multiple pregnancies?. Human Reprod 2006, 21:701-706.
273. Steure P., van der Steeg J.W., Hompes P.G.A., et al. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomized clinical trial. Lancet 2006, 368:216-220.
274. Reindollar R.H., Regan M.M., Neumann P.J., Levine B.S., et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT trial). Fertil Steril 2010, 94:888-899.
275. Reindollar R.H., Goldman M.B. Gonadotropin therapy: a 20th century relic. Fertil Steril 2012, 97:813-818.
276. McClamrock H.D., Jones H.W., Adashi E.Y. Ovarian stimulation and intrauterine insemination at the quarter centennial: implications for the multiple births epidemic. Fertil Steril 2012, 97:802-809.
277. Diamond M.P., Singh M. Use of gonadotropins for initiation of singleton gestations in non-assisted reproductive technology cycles. Fertil Steril 2012, 97:810-812.
278. Sengoku K., Tamate K., Takaoka Y., et al. A randomized prospective study of gonadotropin with or without gonadotropin releasing hormone agonist for treatment of unexplained infertility. Human Reprod 1994, 9:1043-1047.
279. Cantineau A.E.P., Cohlen B.J., Klip H., Heineman M.J., et al. The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates-a randomized, double-blinded, placebo-controlled trial. Human Reproduction 2011, 26:1104-1111.
280. Pandian Z., Gibreel A., Bhattacharya S. In vitro fertilisation for unexplained subfertility. Cochrane Database Syst Rev 2012, CD003357.
281. Custers I.M., Konig T.E., Broekmans F.J., Hompes P.G.A., et al. Couples with unexplained subfertility and unfavourable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation. Fertil Steril 2011, 96:1107-1111.
282. Aboulghar M.A., Mansour R.T., Serour G.I., et al. Management of long standing unexplained infertility: a prospective study. Am J Obstet Gynecol 1999, 181:371-375.
283. Gurgan T., Urman B., Yarali H., Kisnisci H.A. The results of in vitro fertilization embryo transfer in couples with unexplained infertility failing to conceive with Superovulation and intrauterine insemination. Fertil Steril 1995, 64:93-97.
284. Smith J.F., Eisenberg M.L., Millstein S.G., Nachtigall R.D., et al. Fertility treatments and outcomes among couples seeking fertility care: data from a prospective fertility cohort in the United States. Fertil Steril 2011, 95:79-84.
285. Yentis S.M., Steer P.J., Plaat F. Eisenmenger's syndrome in pregnancy: maternal and fetal mortality in the 1990's. Br J Obstet Gynecol 1998, 105:921-924.
286. Practice Committee of the American Society of Reproductive Medicine Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril 2011, 97:282-284.
287. Braat D.D.M., Schutte J.M., Bernardus R.E., Mooij T.M. Maternal death related to IVF in the Netherlands 1984-2008. Hum Reprod 2010, 25:1782-1786.
288. Pandey S., Maheshwari A., Bhattacharya S. Should access to fertility treatment be determined by female body mass index. Hum Reprod 2010, 25:815-820.
289. Marshall N.E., Guild C., Cheng Y.W., Caughey A.B., et al. Maternal superobesity and perinatal outcomes. Am J Obstet Gynecol 2012, 206. 417.e1-6.
290. Zhu J.L., Obel C., Bech B.H., Olsen J., et al. Infertility, infertility treatment and fetal growth restriction. Obstet Gynecol 2007, 110:1326-1334.
291. Raatikainen K., Kuivasaari-Pirinen P., Hippelainen M., Heinonen S. Comparison of the pregnancy outcomes of subfertile women after infertility treatment and naturally conceived pregnancies. Hum Reprod 2012, 27:1162-1169.
292. Romundstad L.B., Romundstad P.R., Sunde A., von During V., et al. Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet 2008, 372:737-743.
293. Cooper A.R., O'Neill K.E., Allsworth J.E., Jungheim E.S., et al. Smaller fetal size in singletons after infertility therapies: the influence of technology and the underlying infertility. Fertil Steril 2011, 96:1100-1106.
294. Campagne D.M. Should fertilization treatment start with reducing stress. Human Reprod 2006, 21:1651-1655.
295. Klonoff-Cohen H., Chu E., Natarajan L., Sieber W. A prospective study of stress among women undergoing in vitro fertilization or gamete intrafallopian tube transfer. Fertil Steril 2001, 76:675-687.
296. Domar A.D., Clapp D., Slawsby E.A., et al. Impact of group psychological interventions on pregnancy rates in infertile women. Fertil Steril 2000, 73:805-811.
297. Seibel M.M., Levin S. A new era in reproduction technologies: the emotional stages of in vitro fertilization. J In Vitro Fert Embryo Transf 1987, 4:135-140.
298. Wasser S.K., Sewall G., Soules M.R. Psychosocial stress as a cause of infertility. Fertil Steril 1993, 59:685-689.
299. Menning B.E. The emotional needs of infertile couples. Fertil Steril 1980, 34:313-319.
300. Freeman W.E., Rickels K., Tausig J., et al. Emotional and psychosocial factors in follow-up of women after IVF-ET treatment: a pilot investigation. Acta Obstet Gynecol Scand 1987, 66:517-521.
301. Dancet E.A.F., Van Empel I.W.H., Rober P., Nelen W.L.D.M., et al. Patient-centered infertility care: a qualitative study to listen to the patient's voice. Hum Reprod 2011, 26:827-833.
302. Domar A., Gordon K., Garcia-Velasco J., La Marca A., et al. Understanding the perceptions of and emotional barriers to infertility treatment: a survey in four European countries. Hum Reprod 2012, 27:1073-1079.
303. Mourad S.M., Nelen W.L.D.M., Akkermans R.P., Vollebergh J.H.A., et al. Determinants of patients' experiences and satisfaction with fertility care. Fertil Steril 2010, 94:1254-1260.
304. Cakmak H., Taylor H.S. Implantation failure: molecular mechanism and clinical treatment. Hum Reprod Update 2011, 17:242-253.
305. Caronia L.M., Martin C., Welt C.K., Sykiotis G.P., et al. A genetic basis for functional hypothalamic amenorrhea. N Engl J Med 2011, 364:215-225.
306. Cooper T.G., Noon E., von Eckardstein S., Auger J., et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update 2010, 16:231-245.
307. De Ziegler D., Borghese B., Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet 2010, 376:730-738.
308. Dhont N., van de Wijgert J., Coene G., Gasarabwe A., et al. "Mama and pap nothing": living with infertility among an urban population of Kigali, Rwanda. Hum Reprod 2011, 26:623-629.
309. Fledderjohann J.J. "Zero is not good for me": implications of infertility in Ghana. Hum Reprod 2012, 27:1383-1390.
310. Maggard M.A., Yermilov I., Li Z., Maglione M., et al. Pregnancy and fertility following bariatric surgery. JAMA 2008, 300:2286-2296.
311. Romundstad L.B., Romundstad P.R., Sunde A., von During V., et al. Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet 2008, 372:737-743.
312. Stillman R.J. A 47-year old woman with fertility problems who desires a multiple pregnancy. JAMA 2007, 297:858-867.
313. White Y.A.R., Woods D.C., Takai Y., Ishihara O., et al. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nature Medicine 2012, 18:413-421.